Posted 3/27/2014 7:23 PM (GMT 0)
There is a ongoing trial now of SBRT of this, called "heterogeneous planning" or intraprostatic boosting. The idea is to more closely mimic the way HDR brachy is applied - more dose in some regions than in others. Early results are showing good effectiveness without undue toxicity, but so far not any better than homogeneous planning. The homogeneous planners argue that there are often microscopic foci that do not show up in any of even the best imaging. They argue that the biologically effective dose is already very high throughout the prostate (much higher than anything achievable with conventional IMRT), and the dose to organs at risk (bladder, rectum) is already very low. I personally doubt that it makes a difference.